Background: Despite its unique regenerative capacity, bone healing can be compromised, leading to delayed fracture regeneration and consequently nonunion. Due to the scarcity of autografts and the problems associated with a supraphysiological use of rhBMP-2, novel tissue engineering strategies arise as a promising solution to overcome nonunions and related bone pathologies. Purpose: To clinically deal with fracture nonunion, we designed engineered mimetic autografts consisting of a personalized polycaprolactone (PCL) scaffold surrounded by a porous PCL membrane mimicking the periosteum synthesized by melt electrowriting (MEW) (Figure 1). Methods: MEW membrane was functionalized with poly ethyl acrylate (PEA) and Fibronectin for efficient rh...
Background: Biomaterial scaffolds that deliver growth factors such as recombinant human bone morphog...
The aim of this study was to develop 3-D tissue engineered constructs that mimic the in vivo conditi...
© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim While new biomaterials...
During bone regeneration, the periosteum acts as a carrier for key regenerative cues, delivering ost...
Introduction: Despite its regenerative capacity, bone healing can be compromised, leading to delayed...
Bone presents truly regenerative capacity being able to regenerate into a native state in response ...
An attractive alternative to bone autografts is the use of autologous mesenchymal progenitor cells (...
The hypothesis of this study was that the extent of bone regeneration could be enhanced by using sca...
Abstract Background There is a critical need for the management of large bone defects. The purpose o...
Clinical translation of cell-based strategies for regenerative medicine demands predictable in vivo ...
We describe two studies encompassing the iterative refinement of a polymer-based rhBMP-2 delivery sy...
peer reviewedBone fractures are one of the most common traumatic large-organ injuries and although ...
The reconstruction of large defects (>10 mm) in humans usually relies on bone graft transplan...
[[abstract]]Introduction: Congenital or acquired bone defects are major problems in orthopedic surge...
The reconstruction of large defects (>10 mm) in humans usually relies on bone graft transplantation....
Background: Biomaterial scaffolds that deliver growth factors such as recombinant human bone morphog...
The aim of this study was to develop 3-D tissue engineered constructs that mimic the in vivo conditi...
© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim While new biomaterials...
During bone regeneration, the periosteum acts as a carrier for key regenerative cues, delivering ost...
Introduction: Despite its regenerative capacity, bone healing can be compromised, leading to delayed...
Bone presents truly regenerative capacity being able to regenerate into a native state in response ...
An attractive alternative to bone autografts is the use of autologous mesenchymal progenitor cells (...
The hypothesis of this study was that the extent of bone regeneration could be enhanced by using sca...
Abstract Background There is a critical need for the management of large bone defects. The purpose o...
Clinical translation of cell-based strategies for regenerative medicine demands predictable in vivo ...
We describe two studies encompassing the iterative refinement of a polymer-based rhBMP-2 delivery sy...
peer reviewedBone fractures are one of the most common traumatic large-organ injuries and although ...
The reconstruction of large defects (>10 mm) in humans usually relies on bone graft transplan...
[[abstract]]Introduction: Congenital or acquired bone defects are major problems in orthopedic surge...
The reconstruction of large defects (>10 mm) in humans usually relies on bone graft transplantation....
Background: Biomaterial scaffolds that deliver growth factors such as recombinant human bone morphog...
The aim of this study was to develop 3-D tissue engineered constructs that mimic the in vivo conditi...
© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim While new biomaterials...